CoChat

Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial

Anand, Amit, Gunn, Abigail D, Barkay, Gavriel, Karne, Harish S, Nurnberger, John I, Mathew, Sanjay J, Ghosh, Samiran · 2012 · Bipolar Disorders
Cited by 65

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, Ghosh S. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial. Bipolar Disord 2012: 14: 64–70. © 2012 The Authors. Journal compilation © 2012 John Wiley & Sons A/S. Background: Recent studies indicate that modulation of glutamate neurotransmission is associated with antidepressant response. Lamotrigine, an anticonvulsant which decreases presynaptic glutamate release, has been shown to be effective in the depressive phase of bipolar disorder (BD‐D); however, only 40–50% of patients have a full response. This pilot study investigated whether memantine, a low‐affinity N‐methyl‐D‐aspartate (NMDA) receptor antagonist approved for Alzheimer’s disease, can augment the effects of lamotrigine. Methods: BD‐D outpatients in a major depressive episode on a stable dose of lamotrigine (100 mg or more) were randomized to either memantine (starting dose of 5 mg increased up to 20 mg over four weeks, then 20 mg stable dose from four to eight weeks) or matching pill placebo for eight weeks. Patients were rated on the 17‐item Hamilton Depression Rating Scale (HDRS) and other behavioral measures weekly. Results: The eight‐week repeated‐measures mixed‐effect model for HDRS was not significant for memantine (n = 14) versus placebo (n = 15). Exploratory mixed‐effect analyses for the first four weeks, while the memantine dose was being titrated up every week, revealed a significant decrease in HDRS scores from baseline (p = 0.007). Conclusion: This proof‐of‐concept study failed to show a statistically significant benefit of memantine augmentation of lamotrigine for patients with BD‐D over eight weeks. However, memantine had an antidepressant effect early on in the treatment while its dose was being titrated up. Larger placebo‐controlled studies are needed to ascertain optimal timing and dosing for memantine augmentation of lamotrigine in BD‐D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2011.00971.x

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 65

Metadata

Authors
Anand, A., Gunn, A. D., Barkay, G., Karne, H. S., Nurnberger, J. I., Mathew, S. J., & Ghosh, S.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2012-02
Volume
14
Issue
1
Pages
64-70
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2135163623
Cited by
65
References
12
FWCI
5.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial. https://app.cochat.ai/papers/10.1111/j.1399-5618.2011.00971.x
The paper
Anand, A., Gunn, A. D., Barkay, G., Karne, H. S., Nurnberger, J. I., Mathew, S. J., & Ghosh, S. (2012). Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double‐blind, randomized, placebo‐controlled trial. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2011.00971.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.